Home Tags Axicabtagene ciloleucel

Tag: axicabtagene ciloleucel

CAR T-cell Therapy Improved Health Related Quality of Life (hrQoL) Six...

Editorial Team -

Axicabtagene Ciloleucel Receives EU Approval for the Treatment of Patients with...

Danielle Garcia -

Substantial Survival Improvement with Axicabtagene Ciloleucel in r/r Follicular Lymphoma

Editorial Team -
Attendees and Speakers during Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies at the American Society of Hematology 60th Annual Meeting at the Orange County Convention Center on, Friday December 6, 2019. Photo courtesy © 2019 ASH/Matt Herp 2019

ASH 2020: Reaching a Broader Patient Population with Cellular Therapies for...

Peter Hofland -
Attendees networking during during the American Society of Clinical Oncology (ASCO) Annual Meeting. Courtesy: ? ASCO/Danny Morton

Sub-population Analysis Shows High Rates of Durable Response and Overall Survival...

Peter Hofland -
Cg render of t-cells

Phase I ZUMA-3 Results for KTE-X19 in ALL Show High Rates...

Peter Hofland -
Attendees during the day at the American Society of Clinical Oncology (ASCO) Courtesy: ? ASCO/Scott Morgan.

New Data From ZUMA Trials Offer Greater Understanding of CAR T-cell...

Peter Hofland -

The Promise of CAR T-Cell Therapy

Peter Hofland -

LATEST NEWS